Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
22.20
-0.66 (-2.89%)
Jun 6, 2025, 2:45 PM CST
SHA:605266 Revenue
Jianzhijia Pharmaceutical Chain Group had revenue of 2.29B CNY in the quarter ending March 31, 2025, a decrease of -0.85%. This brings the company's revenue in the last twelve months to 9.26B, up 0.38% year-over-year. In the year 2024, Jianzhijia Pharmaceutical Chain Group had annual revenue of 9.28B with 2.23% growth.
Revenue (ttm)
9.26B
Revenue Growth
+0.38%
P/S Ratio
0.37
Revenue / Employee
525.56K
Employees
17,625
Market Cap
3.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.28B | 202.15M | 2.23% |
Dec 31, 2023 | 9.08B | 1.57B | 20.84% |
Dec 31, 2022 | 7.51B | 2.28B | 43.54% |
Dec 31, 2021 | 5.23B | 768.60M | 17.21% |
Dec 31, 2020 | 4.47B | 937.83M | 26.58% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |